Status: question. Rule: atlas-profile-2.0.
2 linked publications; not a count of independent studies.
Missing appraisal does not mean no evidence exists. Inspect the full profile and source relationships in the interactive Atlas.
Historical grade: MODERATE (retained from 22 September 2026; not a completed profile 2.0 assessment).
PET could resolve the pseudoprogression problem, but adoption is limited by access and single-center heterogeneous evidence.
PET-RANO/working-group support is largely built on retrospective, heterogeneous-threshold single-center data; outcome-linked prospective evidence is sparse.
Prospective randomized/pragmatic trial: MRI±amino-acid PET for progression assessment with management-change and outcome endpoints; harmonized SUV/TBR thresholds.
This question comes from selected literature. Confirm that the gap remains open with a current search and mentor review.
This is an educational research resource from Resonant Labs, not clinical advice. Atlas assessments are heuristic, not probabilities or formal GRADE ratings. Findings are summarized from the literature and may change as the field evolves.